Dclk1 labels quiescent pancreatic progenitor and cancer initiating cells

被引：1
|
作者：
Westphalen, Christoph Benedikt [1 ]
Quante, Michael [2 ]
Worthley, Daniel [1 ]
Asfaha, Samuel [1 ]
Remotti, Helen [1 ]
Olive, Kenneth P. [1 ]
Wang, Timothy C. [1 ]
机构：
[1] Columbia Univ, Med Ctr, New York, NY USA
[2] Tech Univ Munich, D-80290 Munich, Germany
来源：
CANCER RESEARCH | 2012年 / 72卷
关键词：
D O I：
10.1158/1538-7445.AM2012-5220
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
5220
引用
收藏
页数：1
相关论文
共 50 条
  • [31] Enhancement of cytotoxic effects of gemcitabine by Dclk1 inhibition through suppression of Chk1 phosphorylation in human pancreatic cancer cells
    Kawamura, Daichi
    Takemoto, Yoshihiro
    Nishimoto, Arata
    Ueno, Koji
    Hosoyama, Tohru
    Shirasawa, Bungo
    Tanaka, Toshiki
    Kugimiya, Naruji
    Harada, Eijiro
    Hamano, Kimikazu
    ONCOLOGY REPORTS, 2017, 38 (05) : 3238 - 3244
  • [32] UNRAVELING THE ROLE OF DCLK1 ISOFORMS IN COLITIS AND COLON CANCER
    Yusuf, Kafayat A.
    Roy, Badal
    Anant, Shrikant
    Umar, Shahid
    GASTROENTEROLOGY, 2024, 166 (05) : S1274 - S1274
  • [33] DCLK1 Plays a Metastatic-Promoting Role in Human Breast Cancer Cells
    Liu, Heshu
    Wen, Tao
    Zhou, Ying
    Fan, Xiaona
    Du, Tan
    Gao, Tianbo
    Li, Lina
    Liu, Jian
    Yang, Lei
    Yao, Jiannan
    Ge, Yang
    An, Guangyu
    BIOMED RESEARCH INTERNATIONAL, 2019, 2019
  • [34] The expression of Dclk1 identifies tuft cells in intestinal epithelium
    Gerbe, F.
    Van Es, J.
    Makrini, L.
    Brulin, B.
    Mellitzer, G.
    Robine, S.
    Romagnolo, B.
    Shroyer, N.
    Bourgaux, J. -F.
    Pignodel, C.
    Clevers, H.
    Jay, P.
    BULLETIN DU CANCER, 2011, 98 : S30 - S30
  • [35] Specific human cholangiocarcinoma (CCA) subpopulations of cancer stem cells (CSCs) express DoubleCortin-Like Kinase 1 (DCLK1) and DCLK1 inhibition induces anti-cancer effects
    Nevi, L.
    Di Matteo, S.
    Carpino, G.
    Cardinale, V.
    Zizzari, I.
    Ambrosino, V.
    Costantini, D.
    Safarikia, S.
    Manzi, E.
    Derose, A. M.
    Melandro, F.
    Bragazzi, M. C.
    Grazi, G.
    Berloco, P. B.
    Giuliante, F.
    Gaudio, E.
    Alvaro, D.
    DIGESTIVE AND LIVER DISEASE, 2018, 50 (01) : 5 - 6
  • [36] A Kinase Inhibitor Specific for DCLK1 Demonstrates Therapeutic Potential Against Human Pancreatic Adenocarcinoma Cells
    Qu, D.
    Weygant, N.
    Berry, W.
    May, R.
    Owen, D.
    Houchen, C. W.
    PANCREAS, 2013, 42 (08) : 1377 - 1378
  • [37] Therapeutic microRNA targeting DCLK1 against colorectal cancer
    Morimoto, Yoshihiro
    Inoue, Akira
    Ikeshima, Ryo
    Yokoyama, Yuhki
    Takahashi, Hidekazu
    Miyoshi, Norikatsu
    Hata, Taishi
    Matsuda, Chu
    Mizushima, Tsunekazu
    Doki, Yuichiro
    Mori, Masaki
    Yamamoto, Hirofumi
    CANCER SCIENCE, 2018, 109 : 1011 - 1011
  • [38] Pancreatic Neuroendocrine Tumors and EMT Behavior Are Driven by the CSC Marker DCLK1
    Ikezono, Yu
    Koga, Hironori
    Akiba, Jun
    Abe, Mitsuhiko
    Yoshida, Takafumi
    Wada, Fumitaka
    Nakamura, Toru
    Iwamoto, Hideki
    Masuda, Atsutaka
    Sakaue, Takahiko
    Yano, Hirohisa
    Tsuruta, Osamu
    Torimura, Takuji
    MOLECULAR CANCER RESEARCH, 2017, 15 (06) : 744 - 752
  • [39] Application of RNA-sequencing to identify transcriptome modification by DCLK1 in colorectal cancer cells
    Lianna Li
    Hao Mei
    Abednego Nii Adom Commey
    Cancer Gene Therapy, 2020, 27 : 691 - 701
  • [40] Analysis of the clinical significance of DCLK1+ colorectal cancer using novel monoclonal antibodies against DCLK1
    Dai, Tianqi
    Hu, Yunlong
    Lv, Fulian
    Ozawa, Tatsuhiko
    Sun, Xin
    Huang, Jingjing
    Han, Xiaojian
    Kishi, Hiroyuki
    Muraguchi, Atsushi
    Jin, Aishun
    ONCOTARGETS AND THERAPY, 2018, 11 : 5047 - 5057
12345